The role of thromboxane in cuprophan–induced pulmonary hypertension
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 31 (5) , 1072-1079
- https://doi.org/10.1038/ki.1987.110
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cardiopulmonary effects of cuprophane–activated plasma in the swineKidney International, 1986
- Anaphylatoxin formation during hemodialysis: Comparison of new and re-used dialyzersKidney International, 1983
- Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranesKidney International, 1983
- C3a-induced contraction of guinea pig lung parenchyma: Role of cyclooxygenase metabolitesImmunopharmacology, 1983
- OKY-1581: A selective inhibitor of thromboxane synthesis andProstaglandins, 1981
- Multiple use of dialyzers: Safety and efficacyKidney International, 1981
- Dialysis Symptoms and Stabilization in Long-term DialysisArchives of internal medicine (1960), 1980
- Acute Cardiopulmonary Decompensation and Complement Activation During HemodialysisAnnals of Internal Medicine, 1979
- Complement and Leukocyte-Mediated Pulmonary Dysfunction in HemodialysisNew England Journal of Medicine, 1977
- THE DERIVATION OF TWO DISTINCT ANAPHYLATOXIN ACTIVITIES FROM THE THIRD AND FIFTH COMPONENTS OF HUMAN COMPLEMENTThe Journal of Experimental Medicine, 1968